SAS and Phase Forward, a provider of data management solutions for clinical trials and drug safety, are teaming up to offer a joint offering for clinical trials data integration and analysis.

SAS will incorporate Phase Forward applications into its new SAS Drug Development program.

The integrated offering is intended to the joint offering is streamline work processes for drug development from study design to analysis and submission. The companies said the joint deployment should reduce costs and cut time to market.

Phase Forward offers electronic data capture, clinical data management and drug safety applications.

The companies said they would launch collaborative sales and marketing support for the joint product.